Valuation Finch Therapeutics Group, Inc.

Stocks

Market Closed - OTC Markets 19:24:29 02/09/2026 +04			5-day change	1st Jan Change
10.35 ^USD	+1.47%		+1.47%	-23.26%

04-27	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	473.4	22.99	5.797
Change	-	-95.14%	-74.79%
Enterprise Value (EV) ¹	345.9	4.311	10.8
Change	-	-98.75%	150.5%
P/E	-6.72x	-0.2x	-0.08x
PBR	2.34x	0.24x	0.25x
PEG	0.1x	-0x	0x
Capitalization / Revenue	25.5x	26.7x	54.2x
EV / Revenue	18.7x	5.01x	101x
EV / EBITDA	-6x	-0.05x	-0.33x
EV / EBIT	-5.77x	-0.05x	-0.32x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-44.51	-72.12	-46.59
Distribution rate	-	-	-
Net sales ¹	18.53	0.861	0.107
EBITDA ¹	-57.68	-89.61	-32.48
EBIT ¹	-59.98	-95.12	-34
Net income ¹	-58.16	-114.6	-74.75
Net Debt ¹	-127.4	-18.68	5.002
Reference price ²	299.10	14.40	3.61
Nbr of stocks (in thousands)	1,583	1,597	1,606
Announcement Date	31/03/22	23/03/23	25/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FINCH THERAPEUTICS GROUP, INC.	-	-	-	-	16.38M
LONZA GROUP AG	33.93x	6.05x	18x	0.95%	49.74B
REVOLUTION MEDICINES, INC.	-21.45x	254.03x	-23.17x	-.--%	44.98B
IQVIA HOLDINGS INC.	33.27x	3.24x	13.96x	-.--%	42.52B
BEONE MEDICINES AG	46.98x	5.43x	29.72x	-.--%	40.78B
CELLTRION, INC.	28.55x	8.63x	21.82x	0.4%	32.89B
MEDPACE HOLDINGS, INC.	33.17x	5.43x	24.66x	-.--%	16.28B
EUROFINS SCIENTIFIC SE	23.86x	2.08x	9x	1.13%	14.4B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	75.53x	3.99x	15.46x	-.--%	13.48B
Average	31.73x	36.11x	13.68x	0.31%	28.34B
Weighted average by Cap.	27.03x	49.18x	12.22x	0.3%